Regulatory
FDA Approves Takeda’s Orzeyful, a First-in-Class Drug for Narcolepsy Type 1
The orexin-boosting pill treats the underlying biology of narcolepsy type 1 — keeping patients awake and curbing cataplexy — and opens a lucrative new drug class.